SEARCH

SEARCH BY CITATION

References

  • 1
    Uhle, F. C. & Harris, L. S. (1956) The synthesis of alpha-methylamino acids. Journal of the American Chemistry Society, 78, 381384.
  • 2
    Uhle, F. C. & Harris, L. S. (1957) The synthesis and cyclication of alpha-methylamino (4-carboxy-3-in dole)-propionic acid. Journal of the American Chemistry Society, 79, 102109.
  • 3
    Harris, L. S. & Uhle, F. C. (1960) 4-substituted indoles as antagonists to 5-hydroxy-tryptomine and to the veratrine response. Journal of Pharmacology and Experimental Therapeutics, 128, 358362.
  • 4
    Harris, L. S. & Uhle, F. C. (1961) Enhancement of amphetamine stimulation and prolongation of barbiturate depression by a substituted pyrid (3,4-B) indole derivative. Journal of Pharmacology and Experimental Therapeutics, 232, 251257.
  • 5
    Harris, L. S., Clarke, R. L. & Dembinski, J., (1963) Benzyltetrahydrofurfurylamines. A new series of psychomotor stimulants. III. The pharmacology of d-threo-a-benzyl-N-ethyltetrahydrofurfurylamine-(zylofuramine). Archives Internationale de Pharmacodynamic et de Therapie, 146, 392405.
  • 6
    Archer, S., Albertson, N. F., Harris, L. S., Pierson, A. K., Bird, J. G., Keats, A. S. et al. (1962) Narcotic antagonists as analgesics. Science, 137, 541543.
  • 7
    Harris, L. S. & Pierson, A. K. (1964) Some narcotic antagonists in the benzomorphan series. Journal of Pharmacology and Experimental Therapeutics, 143, 141148.
  • 8
    Lasagna, L., Dekornfeld, T. & Pearson, J. W. (1964) The analgesic efficacy and respiratory effects in man of a benzomorphan ‘narcotic antagonist’. Journal of Pharmacology and Experimental Therapeutics, 144, 1216.
  • 9
    Martin, W. R., Gorodetzky, C. W. & Mcclane, T. K. (1969) An experimental study in the treatment of narcotic addicts with cyclazocine. Clinical Pharmacology and Therapeutics, 7, 455465.
  • 10
    Harris, L. S. (1986) Nathan B. Eddy Memorial Award Lecture. Problems of Drug Dependence, 67, 413.
  • 11
    Harris, L. S. (1970) Central neurohumoral systems involved with narcotic agonists and antagonists. Federal Proceedings, 29, 2832.
  • 12
    Dewey, W. L., Harris, L. S., Howes, J. D., Kennedy, J. S., Granchelli, F. E., Pars, H. G. et al. (1978) Pharmacology of some marijuana constituents and two heterocyclic analogues. Nature, 226, 12651267.
  • 13
    Harris, L. S., Dewey, W. L. & Razdan, R. K. (1977) Cannabis, its chemistry, pharmacology and toxicology. In: Martin, W., ed. The Handbook of Experimental Pharmacology Drug Addiction, Vol. II, pp. 45. 371–429. Berlin, Germany: Springer-Verlag.
  • 14
    Harris, L. S., Carchman, R. A. & Martin, B. R. (1978) Evidence for the existence of specific cannabinoid binding sites. Life Science, 22, 11311138.
  • 15
    Mcmillan, D. E., Harris, L. S., Frankenheim, J. M. & Kennedy, J. S. (1970) 1-Trans-delta-tetrahydrocannabinol in pigeons: tolerance to the behavioral effects. Science, 169, 501503.
  • 16
    Martin, B. R., Dewey, W. L., Harris, L. S. & Beckner, J. S. (1976) H-delta-9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs. Journal of Pharmacology and Experimental Therapeutics, 196, 128144.
  • 17
    Aceto, M. D., Scates, S. M., Lowe, J. A. & Martin, B. R. (1996) Dependence on Δ9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. Journal of Pharmacology and Experimental Therapeutics, 278, 12901295.
  • 18
    Annual Reports (19752005) Proceedings of the Committee (College) on Problems of Drug Dependence. National Academy of Sciences, Washington, D.C. 1975–1978 and National Institute on Drug Abuse, Rockville, MD, 1979–2005.
  • 19
    World Health Organization (WHO) (197794) Technical Report Series. Geneva: WHO.